{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:06:23Z","timestamp":1789653983103,"version":"4.0.0"},"reference-count":65,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Stage F3 liver fibrosis represents a critical phase for intercepting the progression toward irreversible cirrhosis. Despite its clinical significance, effective interventions remain scarce. Clinical observations indicate that the traditional Chinese medicine (TCM) formula Qijia Rougan Formula (QRF) exhibits pronounced anti-fibrotic efficacy specifically at Stage F3. Preliminary data suggest that QRF may exert immunomodulatory and anti-fibrotic effects by targeting NLRP3 inflammasome\/GSDMD axis. Its precise mechanistic underpinnings warrant further elucidation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      C57BL\/6 mice were administered CCl\n                      <jats:sub>4<\/jats:sub>\n                      to establish stage F3 model. Following a 6-week therapeutic regimen, hepatic structural integrity and functional recovery were assessed. A multi-tiered investigative strategy was employed: molecular docking predicted ligand-protein interactions, while transcriptomic profiling identified differentially expressed genes (DEGs).\n                      <jats:italic>In vitro<\/jats:italic>\n                      , LPS\/ATP-primed macrophages were treated with QRF-medicated serum. The ultrastructural hallmarks of pyroptosis were visualized using transmission electron microscopy (TEM). A functional rescue experiment was performed using NLRP3-specific agonist Nigericin (NIG) to establish causality.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>High-dose QRF significantly ameliorated hepatic dysfunction and histopathological injury in F3 model mice. Integrated in molecular docking and transcriptomic analysis identified the NLRP3-mediated pyroptotic pathway as QRF\u2019s primary therapeutic target. Specifically, QRF suppressed NLRP3, Caspase-1, and GSDMD expression, thereby curtailing pro-inflammatory cytokines (IL-1\u03b2, IL-18) and LDH release. Concurrently, QRF facilitated a macrophage phenotypic switch from the pro-inflammatory M1 to the anti-inflammatory M2 phenotype. TEM confirmed that QRF preserved membrane integrity and mitigated organelle damage. Notably, the anti-pyroptotic efficacy of QRF was abolished by NIG, confirming its dependence on NLRP3 inhibition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>QRF exerts significant anti-fibrotic activity in stage F3 fibrosis by inhibiting NLRP3\/Caspase-1\/GSDMD mediated macrophage pyroptosis. By quenching this pathway, QRF curtails the inflammatory cascade and promotes M1-to-M2 macrophage polarization, thereby optimizing intrahepatic immune microenvironment and retarding fibrotic progression. Utilizing the reliable established F3 animal model, these findings systematically elucidate the QRF\u2019s key targets and provide experimental foundation for developing stage-specific therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1796042","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T04:16:52Z","timestamp":1777954612000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Qijia Rougan Formula alleviates liver fibrosis by inhibiting NLRP3-mediated pyroptosis and regulating macrophage polarization"],"prefix":"10.3389","volume":"17","author":[{"given":"Xin","family":"Ding","sequence":"first","affiliation":[{"name":"College of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]},{"name":"College of Traditional Chinese Medicine, Inner Mongolia Medical University","place":["Hohhot, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baixue","family":"Li","sequence":"additional","affiliation":[{"name":"College of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfei","family":"Song","sequence":"additional","affiliation":[{"name":"College of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhao","family":"Liu","sequence":"additional","affiliation":[{"name":"College of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenglong","family":"Zheng","sequence":"additional","affiliation":[{"name":"College of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jibin","family":"Liu","sequence":"additional","affiliation":[{"name":"College of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wen","sequence":"additional","affiliation":[{"name":"College of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quansheng","family":"Feng","sequence":"additional","affiliation":[{"name":"College of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116952","article-title":"Gentiopicroside improves NASH and liver fibrosis by suppressing TLR4 and NLRP3 signaling pathways","volume":"177","author":"Yong","year":"2024","journal-title":"BioMed Pharmacother"},{"key":"B2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13287-018-1122-8","article-title":"Transplantation of bone marrow mesenchymal stromal cells attenuates liver fibrosis in mice by regulating macrophage subtypes","volume":"10","author":"Luo","year":"2019","journal-title":"Stem Cell Res Ther"},{"key":"B3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13062-025-00612-3","article-title":"Inhibition of RAC1 activator DOCK2 ameliorates cholestatic liver injury via regulating macrophage polarisation and hepatic stellate cell activation","volume":"20","author":"Qiu","year":"2025","journal-title":"Biol Direct"},{"key":"B4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","article-title":"Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues","volume":"65","author":"Parola","year":"2019","journal-title":"Mol Aspects Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(24)00437-0","article-title":"Staging liver fibrosis and cirrhosis using non-invasive tests in people with chronic hepatitis B to inform WHO 2024 guidelines: a systematic review and meta-analysis","volume":"10","author":"Liguori","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B6","article-title":"Guidelines for the diagnosis and treatment of liver fibrosis with integrated traditional Chinese and Western medicine (2019 edition)","volume":"35","author":"Xu","year":"2019","journal-title":"Chin J Integr Trad West Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-023-00796-x","article-title":"Antifibrotic therapy in nonalcoholic steatohepatitis: time for a human-centric approach","volume":"20","author":"Brennan","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-022-00874-x","article-title":"Histological assessment based on liver biopsy: the value and challenges in NASH drug development","volume":"43","author":"Tong","year":"2022","journal-title":"Acta Pharmacol Sin"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2022.155271","article-title":"S100a16 deficiency prevents hepatic stellate cells activation and liver fibrosis via inhibiting CXCR4 expression","volume":"135","author":"Zhang","year":"2022","journal-title":"Metabolism"},{"key":"B10","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3892\/mmr.2022.12724","article-title":"Crosstalk between NK cells and hepatic stellate cells in liver fibrosis (Review)","volume":"25","author":"Zhang","year":"2022","journal-title":"Mol Med Rep"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.120029","article-title":"Biejia ruangan tablet alleviated liver fibrosis in murine models by hindering the crosstalk between hepatic stellate cells and M2-like macrophages through PDGF-AA\/PI3K\/AKT pathway","volume":"350","author":"Chen","year":"2025","journal-title":"J Ethnopharmacol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155974","article-title":"Lithospermic acid improves liver fibrosis through Piezo1-mediated oxidative stress and inflammation","volume":"134","author":"Luo","year":"2024","journal-title":"Phytomedicine"},{"key":"B13","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3892\/mmr.2025.13599","article-title":"Polygonatum sibiricum polysaccharide alleviates liver fibrosis through the TGF\u2212beta\/Smad signaling pathway and reduces collagen","volume":"32","author":"Yuan","year":"2025","journal-title":"Mol Med Rep"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118018","article-title":"Progress in clinical and basic research of fuzheng Huayu formula for the treatment of liver fibrosis","volume":"327","author":"Zhou","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.70045","article-title":"Recent advances in the investigation of the role and immunoregulatory mechanisms of polysaccharides from traditional chinese medicine in the intervention of liver cirrhosis","volume":"39","author":"Cui","year":"2025","journal-title":"Phytother Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2022.00091","article-title":"An-luo-hua-xian pill improves the regression of liver fibrosis in chronic hepatitis B patients treated with entecavir","volume":"11","author":"Liu","year":"2023","journal-title":"J Clin Transl Hepatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4494099","article-title":"Efficacy and safety of a botanical formula fuzheng huayu for hepatic fibrosis in patients with CHC: results of a phase 2 clinical trial","volume":"2022","author":"Hassanein","year":"2022","journal-title":"Evid Based Complement Alternat Med"},{"key":"B18","article-title":"Academic ideology exploration of treating hepatic cirrhosis through regulating the \u201cSpleen\u201d by professor fengQuansheng, chengdu university of traditional chinese medicine","author":"Dou","year":"2019"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1347120","article-title":"Gut microbes combined with metabolomics reveal the protective effects of Qijia Rougan decoction against CCl(4)-induced hepatic fibrosis","volume":"15","author":"Li","year":"2024","journal-title":"Front Pharmacol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115794","article-title":"Qijia rougan formula ameliorates ECM deposition in hepatic fibrosis by regulating the JAK1\/STAT6-microRNA-23a feedback loop in macrophage M2 polarization","volume":"168","author":"Zheng","year":"2023","journal-title":"BioMed Pharmacother"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.13422\/j.cnki.syfjx.20251193","article-title":"Efficacy of Qijia Rougan decoction combined with entecavir in staged treatment of chronic hepatitis B liver fibrosis with qi deficiency and blood stasis syndrome: A study based on the theory of \u2018Zhu Ke Jiao\u2019","volume":"32","author":"Li","year":"2026","journal-title":"Chin J Exp Traditional Med Formulae"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117334","article-title":"TMT-based proteomics analysis identifies the interventional mechanisms of Qijia Rougan decoction in improving hepatic fibrosis","volume":"319","author":"Chen","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"B23","article-title":"Astragaloside IV inhibits liver fibrosis by acting on CXCL12\/CXCR4 signal axisand TXNIP\/NLRP3 inflammasome pathway","volume":"54","author":"Su","year":"2023","journal-title":"Chin Traditional Herbal Drugs"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/cells11223579","article-title":"S100A8-mediated NLRP3 inflammasome-dependent pyroptosis in macrophages facilitates liver fibrosis progression","volume":"11","author":"Liu","year":"2022","journal-title":"Cells"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102691","article-title":"STING mediates hepatocyte pyroptosis in liver fibrosis by Epigenetically activating the NLRP3 inflammasome","volume":"62","author":"Xiao","year":"2023","journal-title":"Redox Biol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.07.041","article-title":"Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis","volume":"74","author":"Gaul","year":"2021","journal-title":"J Hepatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e2202228","DOI":"10.1002\/adhm.202202228","article-title":"CD44-targeting drug delivery system of exosomes loading forsythiaside A combats liver fibrosis via regulating NLRP3-mediated pyroptosis","volume":"12","author":"Gong","year":"2023","journal-title":"Adv Healthc Mater"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1155\/jamc\/4646858","article-title":"The active ingredients and potential mechanism of qijia rougan decoction in autophagy and hepatic stellate cell activation modulation in liver fibrogenesis","volume":"2025","author":"Li","year":"2025","journal-title":"J Anal Methods Chem"},{"key":"B29","volume-title":"Experimental course of pharmacology of traditional chinese medicine","author":"Wang","year":"2024"},{"key":"B30","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s11626-018-0295-x","article-title":"Effect of Jieduquyuziyin prescription-treated rat serum on MeCP2 gene expression in Jurkat T cells","volume":"54","author":"Li","year":"2018","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"B31","article-title":"Ruan jian qing mai\u2019s formula promotes bone marrow-derived mesenchymal stem cell migration and proliferation","volume":"29","author":"Zong","year":"2023","journal-title":"Altern Ther Health Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155878","article-title":"Glycyrrhizic acid ameliorates hepatic fibrosis by inhibiting oxidative stress via AKR7A2","volume":"133","author":"Wang","year":"2024","journal-title":"Phytomedicine"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-1382-5_23","article-title":"Mouse models of liver fibrosis","volume":"2299","author":"Ravichandra","year":"2021","journal-title":"Methods Mol Biol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s40139-014-0050-2","article-title":"Mouse models of liver fibrosis mimic human liver fibrosis of different etiologies","volume":"2","author":"Martinez","year":"2014","journal-title":"Curr Pathobiol Rep"},{"key":"B35","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1055\/s-2006-927387","article-title":"Mouse models of liver fibrosis","volume":"45","author":"Weiler-Normann","year":"2007","journal-title":"Z Gastroenterol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"10581","DOI":"10.1038\/s41598-020-67396-6","article-title":"Extracellular glucose is crucially involved in the fate decision of LPS-stimulated RAW264","volume":"10","author":"Aki","year":"2020","journal-title":"7 murine macrophage Cells Sci Rep"},{"key":"B37","article-title":"Consensus on evaluation of the diagnosis and eficacy of hepatic fibrosis","volume":"10","year":"2002","journal-title":"Zhonghua Ganzangbing Zazhi"},{"key":"B38","article-title":"Analysis of medication rules of traditional Chinese medicine in the treatment of liver fibrosis based on traditional Chinese Medicine Inheritance computing platform","volume":"32","author":"Yang","year":"2022","journal-title":"Chin J Integrated Traditional Western Med Liver Dis"},{"key":"B39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/transplantology6030025","article-title":"Challenging the dogma: reversal of end-stage liver fibrosis with tirzepatide in MASH cirrhosis","volume":"6","author":"Nguyen","year":"2025","journal-title":"Transplantology"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/foods10112688","article-title":"Astragalus polysaccharides and saponins alleviate liver injury and regulate gut microbiota in alcohol liver disease mice","volume":"10","author":"Zhou","year":"2021","journal-title":"Foods"},{"key":"B41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1089\/cbr.2017.2369","article-title":"Astragalus saponins and liposome constitute an efficacious adjuvant formulation for cancer vaccines","volume":"33","author":"Zhang","year":"2018","journal-title":"Cancer Biother Radiopharm"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2024.135480","article-title":"Vitamin D receptor attenuates carbon tetrachloride-induced liver fibrosis via downregulation of YAP","volume":"478","author":"Wang","year":"2024","journal-title":"J Hazard Mater"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2024.116734","article-title":"Multi-omics analysis and the remedial effects of Swertiamarin on hepatic injuries caused by CCl(4)","volume":"282","author":"Li","year":"2024","journal-title":"Ecotoxicol Environ Saf"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S518793","article-title":"Leonurine attenuates CCl(4)-induced hepatic fibrosis in mice via the hippo-YAP pathway","volume":"19","author":"Wang","year":"2025","journal-title":"Drug Des Devel Ther"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.117975","article-title":"Yinchen gongying decoction mitigates CCl(4)-induced chronic liver injury and fibrosis in mice implicated in inhibition of the FoxO1\/TGF-beta1\/Smad2\/3 and YAP signaling pathways","volume":"327","author":"Feng","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-021-00630-7","article-title":"N-n-Butyl haloperidol iodide ameliorates liver fibrosis and hepatic stellate cell activation in mice","volume":"43","author":"Shen","year":"2022","journal-title":"Acta Pharmacol Sin"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117383","article-title":"Bile acids metabolism involved in the beneficial effects of Danggui Shaoyao San via gut microbiota in the treatment of CCl(4) induced hepatic fibrosis","volume":"319","author":"Zhao","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31987","article-title":"Single-cell transcriptomic analysis reveals a hepatic stellate cell-activation roadmap and myofibroblast origin during liver fibrosis in mice","volume":"74","author":"Yang","year":"2021","journal-title":"Hepatology"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107151","article-title":"Amygdalin inhibits TGFbeta1-induced activation of hepatic stellate cells (HSCs) in vitro and CCl(4)-induced hepatic fibrosis in rats in vivo","volume":"90","author":"Wang","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1159\/000495829","article-title":"Sestrin 2 Attenuates Rat Hepatic Stellate Cell (HSC) Activation and Liver Fibrosis via an mTOR\/AMPK-Dependent Mechanism","volume":"51","author":"Hu","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e1011858","DOI":"10.1371\/journal.pcbi.1011858","article-title":"A rule-based multiscale model of hepatic stellate cell plasticity: Critical role of the inactivation loop in fibrosis progression","volume":"20","author":"Bougueon","year":"2024","journal-title":"PloS Comput Biol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13578-025-01376-z","article-title":"Clusterin deficiency exacerbates cholestatic liver disease through ER stress and NLRP3 inflammasome activation","volume":"15","author":"Seo","year":"2025","journal-title":"Cell Biosci"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109321","article-title":"Ursolic acid alleviates Kupffer cells pyroptosis in liver fibrosis by the NOX2\/NLRP3 inflammasome signaling pathway","volume":"113","author":"Wan","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2021.104761","article-title":"Enterococcus Faecalis activates NLRP3 inflammasomes leading to increased interleukin-1 beta secretion and pyroptosis of THP-1 macrophages","volume":"154","author":"Ran","year":"2021","journal-title":"Microb Pathog"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1601350","article-title":"Inflammasomes in liver fibrosis","volume":"37","author":"Alegre","year":"2017","journal-title":"Semin Liver Dis"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1444100","article-title":"Chitinase 1: a novel therapeutic target in metabolic dysfunction-associated steatohepatitis","volume":"15","author":"Cha","year":"2024","journal-title":"Front Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2021.07.014","article-title":"Photodynamic therapy induces human esophageal carcinoma cell pyroptosis by targeting the PKM2\/caspase-8\/caspase-3\/GSDME axis","volume":"520","author":"Li","year":"2021","journal-title":"Cancer Lett"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/s10266-025-01304-0","article-title":"Rg1 activates the AMPK\/mTOR-autophagy axis and inhibits the NOD-like receptor 3 inflammasome to alleviate pyroptosis in periodontal ligament fibroblasts","author":"Wang","year":"2026","journal-title":"Odontology"},{"key":"B59","doi-asserted-by":"publisher","first-page":"80","DOI":"10.25259\/Cytojournal_139_2024","article-title":"Geniposide alleviates post-myocardial infarction-induced pyroptosis by modulating the thioredoxin-interacting protein\/NLRP3 signaling pathway","volume":"21","author":"Jiang","year":"2024","journal-title":"Cytojournal"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e19887","DOI":"10.7717\/peerj.19887","article-title":"NLRP3 inflammasome and pyroptosis: implications in inflammation and multisystem disorders","volume":"13","author":"Li","year":"2025","journal-title":"PeerJ"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1526616","article-title":"Cordycepin attenuates NLRP3\/Caspase-1\/GSDMD-mediated LPS-induced macrophage pyroptosis","volume":"16","author":"Liu","year":"2025","journal-title":"Front Pharmacol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.4103\/NRR.NRR-D-24-01381","article-title":"Phosphodiesterase 4 regulates pyroptosis in subarachnoid hemorrhage","volume":"21","author":"Tan","year":"2026","journal-title":"Neural Regener Res"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2017.64","article-title":"Macrophage polarization and function: new prospects for fibrotic disease","volume":"95","author":"Zhou","year":"2017","journal-title":"Immunol Cell Biol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3390\/cells10123509","article-title":"Pyroptosis: mechanisms and links with fibrosis","volume":"10","author":"Song","year":"2021","journal-title":"Cells"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1593689","article-title":"Polysaccharide of Atractylodes macrocephala Koidz alleviate LPS-induced inflammatory liver injury by reducing pyroptosis of macrophage via regulating LncRNA GAS5\/miR-223-3p\/NLRP3 axis","volume":"16","author":"Chen","year":"2025","journal-title":"Front Pharmacol"}],"updated-by":[{"DOI":"10.3389\/fimmu.2026.1945814","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000}}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1796042\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T13:50:18Z","timestamp":1789653018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1796042\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":65,"alternative-id":["10.3389\/fimmu.2026.1796042"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1796042","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"article-number":"1796042"}}